Status:

TERMINATED

Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease

Lead Sponsor:

Weill Medical College of Cornell University

Collaborating Sponsors:

Genentech, Inc.

Conditions:

Chronic Kidney Disease

Eligibility:

All Genders

6-18 years

Phase:

PHASE4

Brief Summary

Circulating concentrations of cytokines, such as leptin, tumor necrosis factor-alpha and interleukins 1 and 6 are increased in patients with chronic kidney disease (CKD). In light of the increasing re...

Detailed Description

Hypothesis: The energy cost of growth is increased in experimental CKD. Caloric intake has been shown to correlate with height velocity in children with CKD, and calorie supplementation has been clear...

Eligibility Criteria

Inclusion

  • Chronic renal insufficiency as defined by the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS; estimated creatinine clearance \< 75 ml/min/1.73 m2 by the Schwartz formula
  • Tanner Stage I or II
  • Availability of growth data for the preceding 6 months, and growth failure defined as height \< 5th percentile for chronological age, and/or SDS score for height more negative than -1.88, and/or height velocity SDS \< 0 for six months

Exclusion

  • Unable or unwilling to adhere to the protocol
  • Additional diagnoses that could impair responsiveness to GH, e.g. dwarfism syndromes or significant extra-renal organ disease, e.g. chronic liver disease, diabetes mellitus, AIDS
  • Taking medications that influence growth
  • Slipped capital femoral epiphysis or avascular necrosis of femoral head
  • Constitutional short stature
  • Lack of growth potential, e.g. closed epiphysis
  • Steroid therapy within previous 3 months
  • Known allergy or sensitivity to rhGH
  • Previous exposure to a growth hormone product (the patients must be naïve to growth hormone)

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2007

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT00194961

End Date

December 1 2007

Last Update

March 25 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Weill Medical College of Cornell University

New York, New York, United States, 10021